Profil

Canti Lorenzo

GIGA

See author's contact details
ORCID
0000-0001-5262-3427
Main Referenced Co-authors
Baron, Frédéric  (12)
Beguin, Yves  (11)
Ehx, Grégory  (9)
Servais, Sophie  (7)
Humblet-Baron, Stéphanie (5)
Main Referenced Keywords
BNT162b2 (3); GVHD (3); Immunology (3); allo-HCT (2); COVID-19 (2);
Main Referenced Unit & Research Centers
GIGA I3-Hematology - ULiège [BE] (1)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (1)
Main Referenced Disciplines
Hematology (12)
Immunology & infectious disease (4)

Publications (total 15)

The most downloaded
182 downloads
Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1 https://hdl.handle.net/2268/260424

The most cited

40 citations (Scopus®)

Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3 https://hdl.handle.net/2268/265878

Canti, L. (2024). Contribution to the study of the immune response to the BNT162b2 vaccine in allogeneic hematopoietic stem cell transplant [Doctoral thesis, ULg - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/313643

Kwan, O., Canti, L., Ehx, G., Beguin, Y., & Baron, F. (06 February 2024). Systems vaccinology study of responses to BNT162b2 vaccine in allogeneic hematopoietic stem cell transplant recipients [Poster presentation]. Séminaire des chercheurs Télévie 2024, Bruxelles, Belgium.
Peer reviewed

Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France.
Peer reviewed

Kwan, O., Canti, L., Ehx, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (16 November 2023). Utilisation de techniques de biologie des systèmes pour une analyse détaillée de la réponse immunitaire au vaccin à ARN messager BNT162b2 chez les patients ayant bénéficié d'une allogreffe [Paper presentation]. 26ème Congrès Annuel de l'Association Française de Cytométrie 2023, Toulouse, France.
Peer reviewed

Kwan, O., Canti, L., Ehx, G., Humblet-Baron, S., & Baron, F. (04 September 2023). Systems vaccinology study of responses to BNT162b2 vaccine in allogeneic hematopoietic stem cell transplant recipients [Poster presentation]. GIGA Day 2023, Liège, Belgium.
Peer reviewed

Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005
Peer Reviewed verified by ORBi

BARON, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., BEGUIN, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology, 13, 827242. doi:10.3389/fimmu.2022.827242
Peer Reviewed verified by ORBi

Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1
Peer Reviewed verified by ORBi

Canti, L., Chrzanowska, A., Doglio, M. G., Martina, L., & Van Den Bossche, T. (2021). Research culture: science from bench to society. Biology Open, 10, 058919. doi:10.1242/bio.058919
Peer Reviewed verified by ORBi

Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3
Peer reviewed
* These authors have contributed equally to this work.

Vandenhove, B., Canti, L., Schoemans, H., Beguin, Y., Baron, F., Graux, C., Kerre, T., & SERVAIS, S. (21 October 2020). How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology, 11, 583564. doi:10.3389/fimmu.2020.583564
Peer Reviewed verified by ORBi

Ritacco, C., Ehx, G., Canti, L., DUBOIS, S., Vandenhove, B., SERVAIS, S., Beguin, Y., & Baron, F. (01 March 2020). Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects. Biology of Blood and Marrow Transplantation, 26 (3), 168. doi:10.1016/j.bbmt.2019.12.028
Peer Reviewed verified by ORBi

Vandenhove, B.* , Canti, L.* , Schoemans, H., BEGUIN, Y., BARON, F., WILLEMS, E., Graux, C., Kerre, T.* , & SERVAIS, S.*. (2020). Acute graft-versus-host disease: diagnosis, pathophysiology and prevention. Belgian Journal of Hematology, 11 (4), 159-173.
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Di Pompo, G., Lemma, S., Canti, L., Rucci, N., Ponzetti, M., Errani, C., Donati, D. M., Russell, S., Gillies, R., Chano, T., Baldini, N., & Avnet, S. (2017). Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma. Oncotarget, 8 (33), 54478-54496. doi:10.18632/oncotarget.17091
Peer Reviewed verified by ORBi

Contact ORBi